47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,8 | 0,8 | 0,1 | -87,4 |
Gross profit (loss) | 1,2 | 1,3 | 0,1 | -88,8 |
EBITDA | 1,3 | 1,4 | 0,1 | -89,3 |
Short time liabilities | 1,6 | 1,7 | 2,2 | 29,6 |
Other operating costs | 0 | 0,6 | 0,3 | -47,3 |
Equity capital | 2,2 | 2,2 | 0,5 | -79,1 |
Operating profit (EBIT) | 1,2 | 1,3 | 0,1 | -91,5 |
Assets | 3,9 | 3,9 | 2,8 | -27,8 |
Net profit (loss) | 1,2 | 1,3 | 0,1 | -88,8 |
Cash | 0,2 | 1 | 0,3 | -69,4 |
Liabilities and provisions for liabilities | 1,7 | 1,7 | 2,4 | 36,8 |
Net income from sale | 15,7 | 16,3 | 14,6 | -10,3 |
Working assets | 3,6 | 3,9 | 2,8 | -28,2 |
Other income costs | 0,4 | 1,1 | 0,3 | -72,3 |
Depreciation | 0,1 | 0 | 0 | -25,2 |
% | % | % | p.p. | |
Profitability of capital | 54,5 | 60,7 | 32,5 | -28,2 |
Equity capital to total assets | 56,5 | 55,8 | 16,1 | -39,7 |
Gross profit margin | 7,6 | 8,1 | 1 | -7,1 |
EBITDA Margin | 8,3 | 8,6 | 1 | -7,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 37 | 39 | 56 | 17 |
Current financial liquidity indicator | 2.268110513687134 | 2.2482755184173584 | 1.2457728385925293 | -1 |
Net dept to EBITDA | 0.02339048869907856 | -0.6656197905540466 | -2.0963311195373535 | -1,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane